Effective December 30, 2022 (the Resignation Date), James Sulat and Bali Muralidhar, M.D., Ph.D. each resigned from the Board of Directors of Exicure, Inc. (the Company). Effective as of the Resignation Date, Mr. Sulat resigned from the Audit Committee and Nominating and Corporate Governance Committee of the Board, and Dr. Muralidhar resigned from the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee of the Board. Appointment of Jiyoung Hwang to the Board of Directors.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.368 USD | +11.52% | -21.94% | -36.24% |
05-16 | Exicure, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
03-22 | North American Morning Briefing : Stocks Struggle After New Records | DJ |
1st Jan change | Capi. | |
---|---|---|
-36.24% | 2.85M | |
+9.85% | 118B | |
+10.29% | 106B | |
-11.03% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.52% | 15.97B | |
+6.90% | 14.03B | |
+17.59% | 11.67B |
- Stock Market
- Equities
- XCUR Stock
- News Exicure, Inc.
- Exicure, Inc. Announces Executive Changes